These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 29137187)
1. Clinical Usefulness of the Platelet-to Lymphocyte Ratio in Patients with Angiosarcoma of the Face and Scalp. Suzuki G; Yamazaki H; Aibe N; Masui K; Sasaki N; Shimizu D; Kimoto T; Asai J; Wada M; Komori S; Katoh N; Yamada K Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29137187 [TBL] [Abstract][Full Text] [Related]
2. Complete Blood Count Score Model Integrating Reduced Lymphocyte-Monocyte Ratio, Elevated Neutrophil-Lymphocyte Ratio, and Elevated Platelet-Lymphocyte Ratio Predicts Inferior Clinical Outcomes in Adult T-Lymphoblastic Lymphoma. Feng X; Li L; Wu J; Zhang L; Sun Z; Li X; Wang X; Yu H; Chang Y; Wu X; Zhou Z; Wang G; Li W; Li Z; Zhang X; Zhang M Oncologist; 2019 Nov; 24(11):e1123-e1131. PubMed ID: 30952822 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic role of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and lymphocyte/monocyte ratio in patients with osteosarcoma. Yapar A; Tokgöz MA; Yapar D; Atalay İB; Ulucaköy C; Güngör BŞ Jt Dis Relat Surg; 2021; 32(2):489-496. PubMed ID: 34145828 [TBL] [Abstract][Full Text] [Related]
4. Neutrophil to lymphocyte ratio, not platelet to lymphocyte or lymphocyte to monocyte ratio, is predictive of patient survival after resection of early-stage pancreatic ductal adenocarcinoma. Pointer DT; Roife D; Powers BD; Murimwa G; Elessawy S; Thompson ZJ; Schell MJ; Hodul PJ; Pimiento JM; Fleming JB; Malafa MP BMC Cancer; 2020 Aug; 20(1):750. PubMed ID: 32782024 [TBL] [Abstract][Full Text] [Related]
5. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer? Deng M; Ma X; Liang X; Zhu C; Wang M Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461 [TBL] [Abstract][Full Text] [Related]
6. A comparison of the neutrophil-lymphocyte, platelet-lymphocyte and monocyte-lymphocyte ratios in schizophrenia and bipolar disorder patients - a retrospective file review. Özdin S; Sarisoy G; Böke Ö Nord J Psychiatry; 2017 Oct; 71(7):509-512. PubMed ID: 28644753 [TBL] [Abstract][Full Text] [Related]
7. Standardized pretreatment inflammatory laboratory markers and calculated ratios in patients with oral squamous cell carcinoma. Grimm M; Rieth J; Hoefert S; Krimmel M; Rieth S; Teriete P; Kluba S; Biegner T; Munz A; Reinert S Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):3371-84. PubMed ID: 26926692 [TBL] [Abstract][Full Text] [Related]
8. Neutrophil and Platelet to Lymphocyte Ratios in Associating with Blood Glucose Admission Predict the Functional Outcomes of Patients with Primary Brainstem Hemorrhage. Fan Z; Hao L; Chuanyuan T; Jun Z; Xin H; Sen L; Juan Q; Cao Y; Mu Y World Neurosurg; 2018 Aug; 116():e100-e107. PubMed ID: 29689388 [TBL] [Abstract][Full Text] [Related]
9. [Effect of preoperative monocyte-lymphocyte ratio on prognosis of patients with resectable esophagogastric junction cancer]. Zhou WJ; Wu J; Li XD; Wang Q; Ni XF; Jiang JT; Ji M; Wu CP Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):178-183. PubMed ID: 28316215 [No Abstract] [Full Text] [Related]
10. The relationship between platelet-to-lymphocyte ratio and pulmonary embolism severity in acute pulmonary embolism. Telo S; Kuluöztürk M; Deveci F; Kirkil G Int Angiol; 2019 Feb; 38(1):4-9. PubMed ID: 30618227 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model. Deng Q; He B; Liu X; Yue J; Ying H; Pan Y; Sun H; Chen J; Wang F; Gao T; Zhang L; Wang S J Transl Med; 2015 Feb; 13():66. PubMed ID: 25885254 [TBL] [Abstract][Full Text] [Related]
12. Elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myeloma. Shi L; Qin X; Wang H; Xia Y; Li Y; Chen X; Shang L; Tai YT; Feng X; Acharya P; Acharya C; Xu Y; Deng S; Hao M; Zou D; Zhao Y; Ru K; Qiu L; An G Oncotarget; 2017 Mar; 8(12):18792-18801. PubMed ID: 27852046 [TBL] [Abstract][Full Text] [Related]
13. Preoperative lymphocyte-monocyte and platelet-lymphocyte ratios as predictors of overall survival in patients with bladder cancer undergoing radical cystectomy. Zhang GM; Zhu Y; Luo L; Wan FN; Zhu YP; Sun LJ; Ye DW Tumour Biol; 2015 Nov; 36(11):8537-43. PubMed ID: 26032095 [TBL] [Abstract][Full Text] [Related]
14. Application of platelet/lymphocyte and neutrophil/lymphocyte ratios in early diagnosis and prognostic prediction in patients with resectable gastric cancer. Lian L; Xia YY; Zhou C; Shen XM; Li XL; Han SG; Zheng Y; Mao ZQ; Gong FR; Wu MY; Chen K; Tao M; Li W Cancer Biomark; 2015; 15(6):899-907. PubMed ID: 26444485 [TBL] [Abstract][Full Text] [Related]
15. Utility of Inflammatory Markers in Predicting Hepatocellular Carcinoma Survival after Liver Transplantation. Ismael MN; Forde J; Milla E; Khan W; Cabrera R Biomed Res Int; 2019; 2019():7284040. PubMed ID: 31737675 [TBL] [Abstract][Full Text] [Related]
16. COMPLETE BLOOD COUNT DERIVED INFLAMMATORY BIOMARKERS IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES. Nanava N; Betaneli M; Giorgobiani G; Chikovani T; Janikashvili N Georgian Med News; 2020 May; (302):39-44. PubMed ID: 32672687 [TBL] [Abstract][Full Text] [Related]
17. Preoperative Neutrophil-Lymphocyte and Lymphocyte-Monocyte Ratios Reflect Immune Cell Population Rearrangement in Resectable Pancreatic Cancer. Sierzega M; Lenart M; Rutkowska M; Surman M; Mytar B; Matyja A; Siedlar M; Kulig J Ann Surg Oncol; 2017 Mar; 24(3):808-815. PubMed ID: 27770341 [TBL] [Abstract][Full Text] [Related]
18. Preoperative Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio Cannot Predict Lymph Node Metastasis and Prognosis in Patients with Early Gastric Cancer: a Single Institution Investigation in China. Zhu GS; Tian SB; Wang H; Ma MG; Liu Y; Du HS; Long YP Curr Med Sci; 2018 Feb; 38(1):78-84. PubMed ID: 30074155 [TBL] [Abstract][Full Text] [Related]
19. Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab? Ulas A; Avci N; Kos T; Cubukcu E; Olmez OF; Bulut N; Degirmenci M J BUON; 2015; 20(3):714-22. PubMed ID: 26214622 [TBL] [Abstract][Full Text] [Related]
20. Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio. Sun W; Zhang L; Luo M; Hu G; Mei Q; Liu D; Long G; Hu G Head Neck; 2016 Apr; 38 Suppl 1():E1332-40. PubMed ID: 26362911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]